• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞因子信号转导抑制因子3(SOCS-3)与肝细胞癌的血管侵犯及总生存期相关。

SOCS-3 is associated with vascular invasion and overall survival in hepatocellular carcinoma.

作者信息

Yang Sheau-Fang, Yeh Yao-Tsung, Wang Shen-Nien, Hung Sz-Chi, Chen Wan-Tzu, Huang Chu-Ho, Chai Chee-Yin

机构信息

Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.

出版信息

Pathology. 2008 Oct;40(6):558-63. doi: 10.1080/00313020802320432.

DOI:10.1080/00313020802320432
PMID:18752121
Abstract

AIMS

Alteration of the suppressor of cytokine signalling-3 (SOCS-3) has been observed in certain human cancers. However, the clinical role of this short-lived protein in hepatocellular carcinoma (HCC) is not well established. Therefore, we aimed to explore the potential role of SOCS-3 proteins in HCC.

METHODS

Paraffin embedded sections from 87 HCC patients were included in this study. The expression patterns of SOCS-3 proteins were analysed using immunohistochemistry and the results were correlated with clinicopathological characteristics and overall survival of the HCC patients.

RESULTS

The SOCS-3 expression of HCC lesions and the adjacent non-tumourous liver tissues was significantly correlated (p = 0.035), while the SOCS-3 expression in HCC lesions was significantly and positively correlated with vascular invasion and histological grading (p = 0.034 and 0.032, respectively). The Kaplan-Meier survival curve showed that the HCC patients with high SOCS-3 expression were associated with a poor overall survival rate in the HCC subgroup with positive vascular invasion (p = 0.014). Furthermore, a multivariate Cox regression model showed that SOCS-3 expression was also a significant determinant of the overall survival for HCC (p = 0.006).

CONCLUSIONS

Our results indicate that altered SOCS-3 expression is associated with the overall survival in a subset of HCC patients with positive vascular invasion. Constitutive and altered SOCS-3 expression may have potential roles in a subset of HCC patients.

摘要

目的

在某些人类癌症中已观察到细胞因子信号传导抑制因子3(SOCS-3)的改变。然而,这种短寿命蛋白在肝细胞癌(HCC)中的临床作用尚未完全明确。因此,我们旨在探讨SOCS-3蛋白在HCC中的潜在作用。

方法

本研究纳入了87例HCC患者的石蜡包埋切片。采用免疫组织化学分析SOCS-3蛋白的表达模式,并将结果与HCC患者的临床病理特征和总生存期相关联。

结果

HCC病变组织与相邻非肿瘤性肝组织中SOCS-3的表达显著相关(p = 0.035),而HCC病变组织中SOCS-3的表达与血管侵犯和组织学分级显著正相关(分别为p = 0.034和0.032)。Kaplan-Meier生存曲线显示,在血管侵犯阳性的HCC亚组中,SOCS-3高表达的HCC患者总生存率较差(p = 0.014)。此外,多变量Cox回归模型显示,SOCS-3表达也是HCC总生存期的一个重要决定因素(p = 0.006)。

结论

我们的结果表明,SOCS-3表达改变与血管侵犯阳性的一部分HCC患者的总生存期相关。组成性和改变的SOCS-3表达可能在一部分HCC患者中具有潜在作用。

相似文献

1
SOCS-3 is associated with vascular invasion and overall survival in hepatocellular carcinoma.细胞因子信号转导抑制因子3(SOCS-3)与肝细胞癌的血管侵犯及总生存期相关。
Pathology. 2008 Oct;40(6):558-63. doi: 10.1080/00313020802320432.
2
Reduced expression of SOCS2 and SOCS6 in hepatocellular carcinoma correlates with aggressive tumor progression and poor prognosis.SOCS2 和 SOCS6 在肝细胞癌中的表达降低与肿瘤侵袭性进展和不良预后相关。
Mol Cell Biochem. 2013 Jun;378(1-2):99-106. doi: 10.1007/s11010-013-1599-5. Epub 2013 Mar 11.
3
Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis.肝细胞癌中甜菜碱同型半胱氨酸甲基转移酶(BHMT)的下调与预后不良相关。
Tumour Biol. 2016 May;37(5):5911-7. doi: 10.1007/s13277-015-4443-6. Epub 2015 Nov 23.
4
Altered p-STAT3 (tyr705) expression is associated with histological grading and intratumour microvessel density in hepatocellular carcinoma.磷酸化信号转导及转录激活因子3(酪氨酸705)表达的改变与肝细胞癌的组织学分级及肿瘤内微血管密度相关。
J Clin Pathol. 2007 Jun;60(6):642-8. doi: 10.1136/jcp.2006.036970. Epub 2006 Aug 10.
5
The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma.细胞因子信号转导抑制因子2(SOCS2)抑制肝细胞癌的肿瘤转移。
Tumour Biol. 2016 Oct;37(10):13521-13531. doi: 10.1007/s13277-016-5215-7. Epub 2016 Jul 28.
6
Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.长链非编码RNA Sox2ot的上调促进肝癌细胞转移并与不良预后相关。
Int J Clin Exp Pathol. 2015 Apr 1;8(4):4008-14. eCollection 2015.
7
Expression Characteristics, Immune Signature, and Prognostic Value of the SOCS Family Identified by Multiomics Integrative Analysis in Liver Cancer.多组学整合分析鉴定的 SOCS 家族在肝癌中的表达特征、免疫特征和预后价值。
Cancer Rep (Hoboken). 2024 Sep;7(9):e2161. doi: 10.1002/cnr2.2161.
8
Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.N-钙黏蛋白表达降低与肝癌的转移潜能和手术预后不良相关。
J Gastroenterol Hepatol. 2012 Jan;27(1):173-80. doi: 10.1111/j.1440-1746.2011.06847.x.
9
Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.肿瘤抑制κ-阿片受体下调预示肝癌患者预后不良。
BMC Cancer. 2017 Aug 18;17(1):553. doi: 10.1186/s12885-017-3541-9.
10
Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.信号转导和转录激活因子4(STAT4)表达降低提示肝细胞癌预后不良且细胞增殖增强。
World J Gastroenterol. 2015 Apr 7;21(13):3983-93. doi: 10.3748/wjg.v21.i13.3983.

引用本文的文献

1
Suppressors of Cytokine Signaling and Hepatocellular Carcinoma.细胞因子信号转导抑制因子与肝细胞癌
Cancers (Basel). 2022 May 22;14(10):2549. doi: 10.3390/cancers14102549.
2
Genetic Deletion of mGlu3 Metabotropic Glutamate Receptors Amplifies Ischemic Brain Damage and Associated Neuroinflammation in Mice.代谢型谷氨酸受体3(mGlu3)的基因缺失会加剧小鼠的缺血性脑损伤及相关神经炎症。
Front Neurol. 2021 Jun 17;12:668877. doi: 10.3389/fneur.2021.668877. eCollection 2021.
3
The prognostic role of BORIS and SOCS3 in human hepatocellular carcinoma.
BORIS和SOCS3在人类肝细胞癌中的预后作用。
Medicine (Baltimore). 2017 Mar;96(12):e6420. doi: 10.1097/MD.0000000000006420.
4
FXR induces SOCS3 and suppresses hepatocellular carcinoma.法尼醇X受体(FXR)诱导细胞因子信号转导抑制因子3(SOCS3)并抑制肝细胞癌。
Oncotarget. 2015 Oct 27;6(33):34606-16. doi: 10.18632/oncotarget.5314.
5
Genomic predictors for recurrence patterns of hepatocellular carcinoma: model derivation and validation.肝细胞癌复发模式的基因组预测因子:模型推导与验证
PLoS Med. 2014 Dec 23;11(12):e1001770. doi: 10.1371/journal.pmed.1001770. eCollection 2014 Dec.
6
Loss of expression and function of SOCS3 is an early event in HNSCC: altered subcellular localization as a possible mechanism involved in proliferation, migration and invasion.SOCS3 的表达缺失和功能丧失是头颈部鳞癌(HNSCC)的早期事件:改变亚细胞定位可能是涉及增殖、迁移和侵袭的机制之一。
PLoS One. 2012;7(9):e45197. doi: 10.1371/journal.pone.0045197. Epub 2012 Sep 18.
7
Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in hepatocellular carcinoma.磷酸化信号转导和转录激活因子3及细胞因子信号转导抑制因子3表达在肝细胞癌中的预后意义
Exp Ther Med. 2011 Jul;2(4):647-653. doi: 10.3892/etm.2011.254. Epub 2011 Apr 11.
8
Leptin inhibits hepatocellular carcinoma proliferation via p38-MAPK-dependent signalling.瘦素通过 p38-MAPK 依赖的信号通路抑制肝癌细胞增殖。
HPB (Oxford). 2011 Apr;13(4):225-33. doi: 10.1111/j.1477-2574.2010.00259.x. Epub 2011 Jan 27.
9
Deregulation of HIF1-alpha and hypoxia-regulated pathways in hepatocellular carcinoma and corresponding non-malignant liver tissue--influence of a modulated host stroma on the prognosis of HCC.肝细胞癌和相应非恶性肝组织中 HIF1-α 和缺氧调节途径的失调——调制宿主基质对 HCC 预后的影响。
Langenbecks Arch Surg. 2010 Apr;395(4):395-405. doi: 10.1007/s00423-009-0590-9. Epub 2010 Feb 18.
10
Loss of SOCS3 expression is associated with an increased risk of recurrent disease in breast carcinoma.SOCS3 表达缺失与乳腺癌疾病复发风险增加相关。
J Cancer Res Clin Oncol. 2010 Oct;136(10):1617-26. doi: 10.1007/s00432-010-0819-6. Epub 2010 Feb 14.